华熙生物(688363.SH)：控股股东增持金额超过区间下限 增持计划尚未实施完毕

Group 1 - The core point of the article is that Huaxi Bio (688363.SH) has announced a share buyback plan, with Huaxi Xinyu having increased its holdings by 3.4969 million shares, representing 0.73% of the total share capital [1] - The total amount spent on the share buyback has reached RMB 201 million, exceeding the lower limit of the planned buyback amount of RMB 200 million [1] - The buyback plan is still in progress and has not yet been fully implemented [1]